Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Hermans

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Diabetes & Metabolism|August 12, 2008
Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective studyP Oriot, J-L Feys, S Mertens de Wilmars, et al.
European Journal of Human Genetics : EJHG|September 14, 1999
Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counsellingM G Ausems, J Verbiest, M P Hermans, et al.
Acta Clinica Belgica|November 11, 1999
Insulin lispro (Humalog) in the treatment of diabetes mellitus: overview of belgian clinical data from global studiesM Bex, M Buysschaert, I De Leeuw, et al.
Human Mutation|December 26, 2003
Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type IIMonique M P Hermans, Dik van Leenen, Marian A Kroos, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Diabetes & Metabolism|August 12, 2008
Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective studyP Oriot, J-L Feys, S Mertens de Wilmars, et al.
European Journal of Human Genetics : EJHG|September 14, 1999
Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counsellingM G Ausems, J Verbiest, M P Hermans, et al.
Acta Clinica Belgica|November 11, 1999
Insulin lispro (Humalog) in the treatment of diabetes mellitus: overview of belgian clinical data from global studiesM Bex, M Buysschaert, I De Leeuw, et al.
Human Mutation|December 26, 2003
Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type IIMonique M P Hermans, Dik van Leenen, Marian A Kroos, et al.
Pageof 8